Ciric To
Impact in
-
- Lung Cancer Treatments and Mutations
- Cell Biology top 10%
- Hippo pathway signaling and YAP/TAZ
Papers in
-
- Lung Cancer Treatments and Mutations 12
-
- Cellular Mechanics and Interactions 2
- Co-authors
- Pasi Antero Janne (11 shared papers)Nathanael S. Gray (8 shared papers)Mierzhati Mushajiang (5 shared papers)Jaebong Jang (6 shared papers)Michael J. Eck (9 shared papers)Dries J.H. De Clercq (4 shared papers)Bo Hee Shin (5 shared papers)Eunyoung Park (3 shared papers)
- Journals
- Cancer Prevention Research (2 papers)Journal of Biological Chemistry (2 papers)Science Translational Medicine (1 paper)Carcinogenesis (1 paper)ACS Medicinal Chemistry Letters (1 paper)
- Partner nations
- United StatesSouth KoreaCanada
In The Last Decade
Ciric To
19 papers receiving 1.4k citations
Ciric To's Hit Papers
Peers
Comparison fields: 5 of 63
- Pulmonary and Respiratory Medicine 666
- Cell Biology 146
- Oncology 218
- Computational Theory and Mathematics 127
- Molecular Biology 389
Countries citing papers authored by Ciric To
This map shows the geographic impact of Ciric To's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ciric To with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ciric To more than expected).
Fields of papers citing papers by Ciric To
This network shows the impact of papers produced by Ciric To. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ciric To. The network helps show where Ciric To may publish in the future.
Co-authors
The 25 scholars most cited alongside Ciric To, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway Hit paper breakdown → | 2020 | 381 |
| 2 | Single and Dual Targeting of Mutant EGFR with an Allosteric Inhibitor Hit paper breakdown → | 2019 | 282 |
| 3 | 2020 | 132 | |
| 4 | 2022 | 114 | |
| 5 | 2019 | 80 | |
| 6 | 2019 | 77 | |
| 7 | 2014 | 68 | |
| 8 | 2022 | 66 | |
| 9 | 2015 | 60 | |
| 10 | 2017 | 43 | |
| 11 | 2010 | 41 | |
| 12 | 2021 | 31 | |
| 13 | 2008 | 29 | |
| 14 | 2022 | 18 | |
| 15 | 2021 | 13 | |
| 16 | 2017 | 10 | |
| 17 | 2024 | 10 | |
| 18 | 2014 | 2 | |
| 19 | 2023 | 1 | |
| 20 | 2023 | 0 |
About Ciric To
Ciric To is a scholar working on Pulmonary and Respiratory Medicine, Cell Biology, Molecular Biology, Oncology and Computational Theory and Mathematics, having authored 20 papers that have together received 1.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (12 papers), Cellular Mechanics and Interactions (2 papers), PARP inhibition in cancer therapy (2 papers), Natural product bioactivities and synthesis (2 papers), Synthesis and biological activity (1 paper), Protein Kinase Regulation and GTPase Signaling (1 paper), TGF-β signaling in diseases (1 paper) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (666 citations), Cell Biology (146 citations), Oncology (218 citations), Computational Theory and Mathematics (127 citations) and Molecular Biology (389 citations). Ciric To has collaborated with scholars based in United States, South Korea and Canada. Frequent co-authors include Pasi Antero Janne, Nathanael S. Gray, Mierzhati Mushajiang, Jaebong Jang, Michael J. Eck, Dries J.H. De Clercq, Bo Hee Shin, Eunyoung Park, David E. Heppner and Thomas W. Gero. Their work appears in journals such as Cancer Prevention Research, Journal of Biological Chemistry, Science Translational Medicine, Carcinogenesis and ACS Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.